Physician profile
Katherine E Webb
NPI 1649247594
$927.08
in general payments reported to CMS, 2019-2025
16 companies · $211 in 2025
The $211 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $266 · 2020: $89.46 · 2021: $142 · 2022: $13.47 · 2023: $64.95 · 2024: $140 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $351 · Education: $64.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $350.99 |
| Education | $64.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $188.05 | 2019-2021 | |
| Astellas Pharma US INC | $158.02 | 2023-2025 | Veozah |
| Sage Therapeutics, LLC | $104.56 | 2024-2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $87.98 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $63.98 | 2021 | |
| Coopersurgical, INC. | $56.17 | 2019 | |
| Pfizer INC. | $53.42 | 2024-2025 | |
| Organon LLC | $46.45 | 2021-2025 | Nexplanon |
| Exeltis, USA INC. | $44.19 | 2025 | Slynd |
| Merck Sharp & Dohme LLC | $30.26 | 2019 | |
| Evofem Biosciences, INC. | $25.82 | 2021 | |
| Sumitomo Pharma America, INC. | $16.51 | 2024 | Myfembree |
| Allergan, INC. | $13.58 | 2019 | |
| Aspira Women'S Health INC | $13.24 | 2020 | |
| Millicent US INC | $12.76 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Meditrina | $12.09 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Webb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.